Large B-cell Lymphoma

• CLINICAL_TRIALS trial_result · 2026-04-17
  Clinical Trial Update: Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL [Phase 1, Phase 2]

  Phase I/II clinical trial update describing the study of Rapcabtagene Autoleucel in chronic lymphocytic leukemia, small lymphocytic lymphoma…

• CLINICAL_TRIALS trial_result · 2025-12-31
  Clinical Trial Update: Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy [Phase 2]

  Phase 2 trial evaluating lymphodepletion with ALLO-647 in adults with Relapsed/Refractory Large B-Cell Lymphoma undergoing ALLO-501A allogen…

• CLINICAL_TRIALS trial_result · 2025-03-27
  Clinical Trial Update: Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting [Phase 4]

  This Phase 4 trial assesses outpatient administration of Yescarta (axicabtagene ciloleucel) for large B-cell lymphoma, including diffuse lar…

• CLINICAL_TRIALS trial_result · 2024-06-28
  Clinical Trial Update: Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma [Phase 1]

  Phase 1 study evaluating the safety and preliminary efficacy of combining axicabtagene ciloleucel with utomilumab in adults with relapsed/re…

• CLINICAL_TRIALS trial_result · 2024-03-04
  Clinical Trial Update: Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma [Phase 1]

  Phase 1 clinical trial examining lenzilumab in combination with axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma was …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-02-20
  Clinical Trial Update: Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Rituximab in Participants With Refractory Large B-Cell Lymphoma [Phase 2]

  Phase 2 study evaluating axicabtagene ciloleucel in combination with rituximab for refractory large B-cell lymphoma has completed with resul…

• CLINICAL_TRIALS trial_result · 2024-01-08
  Clinical Trial Update: Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma [Phase 2]

  A Phase 2 clinical trial update evaluating Relmacabtagene Autoleucel as first-line therapy for high-risk large B-cell lymphoma.

• CLINICAL_TRIALS trial_result · 2022-07-25
  Clinical Trial Update: Study of Efficacy of BZ019 in Large B-cell Lymphoma [Phase 2]

  Phase 2 clinical trial update for BZ019 in Large B-cell Lymphoma.

• CLINICAL_TRIALS trial_result · 2018-08-23
  Clinical Trial Update: Lenalidomide and R-CHOP in B-cell Lymphoma [Phase 1, Phase 2]

  Phase 1/2 trial updating the combination of lenalidomide with R-CHOP in various B-cell lymphomas; study completed.

• CLINICAL_TRIALS trial_result · 2017-05-12
  Clinical Trial Update: Safety and Tolerability of HSC835 in Patients With Hematological Malignancies [Phase 1, Phase 2]

  Phase 1/2 trial assessing safety and tolerability of HSC835 in patients with various hematologic malignancies completed with results posted …